Navigation Links
Opportunities to Invest in Puerto Rico as Global Center for Biotechnology
Date:2/12/2008

25% of world's biological manufacturing capacity is in Puerto Rico

MEXICO CITY, Feb. 12 /PRNewswire/ -- A quarter of the world's biotechnology manufacturing capacity is located in Puerto Rico, making it one of the largest concentrations in the world.

Over the past four years, more than $4 billion has been invested in biotechnology in Puerto Rico by such giants as Eli Lilly, Amgen, Abbot, Ortho Biologics, BD Biosciences and Bristol Myers Squibb. The Puerto Rico Conference, Investment for Growth, organized by the Puerto Rico Chamber of Commerce, will feature a panel on The Biotech Island. Panelists will discuss the factors that are making the island so attractive for this type of investment.

The panelists will include Emilio Rivera, Vice-President of Manufacturing Operations of Amgen Puerto Rico, a company that has expanded twice in the past six years and invested $2 billion; Samuel Malone, President of Eli Lilly & Company Puerto Rico; and Edgardo Fabregas, Vice-President of Pharmaceutical Manufacturing at Johnson & Johnson and the person responsible for the corporation's manufacturing operation in Puerto Rico, Asia and Europe. Eli Lilly built the world's largest modular biotechnology facility in Puerto Rico, where it produces Humalog, recombinant human insulin for the treatment of diabetes.

The Puerto Rico Conference, to be held February 19 & 20 at the Hotel Ritz Carlton in San Juan, is aimed at presenting investment opportunities in Puerto Rico. "We organized the conference around the many areas of interest to investors in which Puerto Rico offers unique opportunities," said Francisco Rodriguez-Castro, organizer and Chair of the Conference. "The response so far has been very positive. We are getting a lot of interest from investors in the U.S. and Puerto Rico," he said. "Our mission is to showcase Puerto Rico's business sector and its many possibilities as we strengthen it with this type of event," said Jose Julian Alvarez, Chairman of the Board of the Puerto Rico Chamber of Commerce.

The conference will also focus on a general presentation of Puerto Rico's economy, growing opportunities in the health sector, and banking, financing vehicles available, real estate investment trusts as a new investment opportunity in Puerto Rico, and developments in tourism, retail and communications.

The Puerto Rico Chamber of Commerce is a non-profit organization established in 1913. It is the most inclusive multi-sector organization on the island and it has traditionally been the voice that represents the private sector. Each year, multiple events, such as this one, are organized to promote and facilitate opportunities that will support the socioeconomic development of Puerto Rico. To make reservations and/or obtain more information, log on to http://www.camarapr.org; or call 1-787-721-6060 extension 2209 from Monday to Friday during work hours (8:00a.m. to 5:00p.m.).

Contact:

Nancy Robles

Puerto Rico Chamber of Commerce

(787) 721-6060 ext. 2209

(787) 474-6092 direct.

Email: nrobles@camarapr.net


'/>"/>
SOURCE Puerto Rico Chamber of Commerce
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. European blood researchers receive award to pursue research opportunities in US
2. Healthcare Tech and the World: Podcast Examines The Challenges & Opportunities for Change in the Healthcare Industry
3. Perdue AgriBusiness Announces Low Linolenic Soybean Contracting Opportunities with DuPont Business Pioneer Hi-Bred
4. Workplace opportunities and stresses are both increasing
5. Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy
6. Holidays Can Present Drinking Opportunities for Teens
7. Biotech Company Builder Papadopoulos Says Investment in Innovation Needed to Advance Drug Pipeline at Massachusetts Biotechnology Councils Ninth Annual MASS Opportunities Investment Conference
8. Alcohol and cancer -- recent research and prevention opportunities
9. In Celebration of Breast Cancer Awareness Month, Susan G. Komen for the Cure San Diego Announces Opportunities for San Diegans to Get Involved in the Fight Against Breast Cancer
10. Investor Insight Initiates Analyst Coverage on Crdentia
11. Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... ... with the Home Care Association of America (HCAOA). This agreement allows HCAOA members ... services, as well as discounts on Accreditation University (AU) educational resources that help ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... 2017 Solentim, the developer of instrumentation ... of a major new product line called the ... VIPS has been developed for automatically seeding single ... part of the process to generate clonally-derived cell ... more reliable solution when compared to traditional single ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: